CDMA taps new VP of sales, marketing

Scot Fine has been named as the new vice president of sales and marketing at the Chain Drug Marketing Association.
Sandra Levy
Senior Editor
Sandra Levy profile picture
a man wearing glasses posing for the camera

The Chain Drug Marketing Association is welcoming a new executive.

Scot Fine is joining the organization as the new vice president of sales and marketing.

Fine, who has more than 20 years of experience in the healthcare industry, most recently served as a consultant at ECEK Capital, and vice president of sales and marketing at Vintage Capital/SteriMed Medical.

[Read more: CDMA names Galvan chairman

“I am very excited to join CDMA,” Fine said. “The Company’s reputation in the marketplace is strong.  CDMA has a strong product portfolio, solid infrastructure, a sound financial position, and an exceptional team of employees. I see opportunities to develop and grow based upon both current and new customer expansion with CDMA products and services.  I am looking forward to contributing my knowledge and leadership skills to grow the business and enhance shareholder value.”

He has also held executive-level roles at Smiths Medical Devices, Radiometer America, and Nova Biomedical.  

[Read More: CDMA donates 45,000 pairs of gloves to 2 Detroit hospitals]

“I am thrilled that Scot has joined our executive team,” said Michael Boivin, CEO of CDMA. “Scot brings a wealth of sales experience and will be a great addition to our team. He shares our commitment for success and is an optimal fit for CDMA’s work culture. We look forward to him stepping into this critical role, to continue to generate new opportunities for our growth and expand our footprint in the private label industry.”